It has been shown that CPX can induce DNA damage and activate the ATR-Chk1 pathway in breast cancer (MDA-MB-231) and rhabdomyosarcoma (Rh30) cells [21]. The gene discussed is ATR; the disease is rhabdomyosarcoma.